《胰高血糖素样肽-1受体激动剂（GLP-1RA）临床应用医药专家共识》学术交流会顺利举办
GLP-1RA作为糖尿病治疗的新秀和热门药物，为糖尿病患者带来了更多药物选择和希望。为此，由广东省药学会组织、广东省人民医院牵头，全国14个省份内分泌、心血管、药学专家参与编写的《胰高血糖素样肽-1受体激动剂（GLP-1RA）临床应用医药专家共识》（以下简称“共识”）已于2023年4月16日正式发布。为进一步推广共识，提高临床和药学人员对于GLP-1RA的认识，规范使用该类药物，为更多的糖尿病患者服务。中山市药学会于2023年7月10日9：00-18：30在中山市锦江都城酒店锦江厅线下+线上的形式举办《胰高血糖素样肽-1受体激动剂（GLP-1RA）临床应用医药专家共识》学术交流会。
会议首先由中山市药学会临床药学专业委员会主任委员邱雄泉主任致辞，邱主任指出：目前糖尿病发病率高，对患者生活质量影响大，医保费用支出高，可喜的是近年来随着新的糖尿病治疗药物进入国家谈判目录，患者得到进一步的治疗。为了更好的提高临床医师和药师对新型降糖药物的认识，中山市药学会举办本次《胰高血糖素样肽-1受体激动剂（GLP-1RA）临床应用医药专家共识》学术交流会。会议首先由中山市中医院内分泌科徐瑞颜主任对GLP-1RA的作用机理和药理效果、分类、适应症与禁忌、临床应用、特殊人群中的应用、药学监护等方面进行讲解。随后由邱雄泉主任对临床药师的培养，提高临床药师工作价值，及如何更好的完善临床药师的工作模式进行演讲。最后中山市中医院内分泌科林泽宏主任为大家带来了《从2022ADA/EASD共识更新，看GLP-1三重获益》的演讲，通过讲解国外共识的变化，传授了对GLP-1RA的使用经验，提高了参会人员治疗糖尿病的水平。
本次会议线上与线下与会听众认真听讲并积极提问发言，提高了对胰高血糖素样肽-1受体激动剂（GLP-1RA）的认识，规范了此类降糖新药的使用和管理。
中山市药学会
2023年8月7日
{"weixin":{"label":"微信","name":"weixin","selected":true,"value":true,"sortid":"1","shareid":"weixin","sharetitle":"分享到微信","event":"shareToWeiXin","lang":"shareWeb_WeiXin"},"copy":{"label":"复制网址","name":"copy","selected":true,"value":true,"sortid":"2","shareid":"copy","sharetitle":"复制网址","event":"copy_url","lang":"shareWeb_Copy"},"qq":{"label":"QQ好友","name":"qq","selected":true,"value":false,"sortid":"1","shareid":"qq","sharetitle":"分享到QQ","event":"shareToQQ","lang":"shareWeb_QQ"},"sina_weibo":{"label":"新浪微博","name":"sina_weibo","selected":true,"value":true,"sortid":"4","shareid":"sina_weibo","sharetitle":"分享到新浪微博","event":"shareToSinaWB","lang":"shareWeb_SinaWeiBo"},"qq_zone":{"label":"QQ空间","name":"qq_zone","selected":true,"value":true,"sortid":"5","shareid":"qq_zone","sharetitle":"分享到QQ空间","event":"shareToQzone","lang":"shareWeb_QQZone"},"renren":{"label":"人人网","name":"renren","selected":true,"value":false,"sortid":"7","shareid":"renren","sharetitle":"分享到人人网","event":"shareToRenren","lang":"shareWeb_RenRen"},"douban":{"label":"豆瓣网","name":"douban","selected":true,"value":true,"sortid":"8","shareid":"douban","sharetitle":"分享到豆瓣网","event":"shareToDouban","lang":"shareWeb_DouBan"},"baidu_tieba":{"label":"百度贴吧","name":"baidu_tieba","selected":true,"value":true,"sortid":"10","shareid":"baidu_tieba","sharetitle":"分享到百度贴吧","event":"shareToTieba","lang":"shareWeb_TieBa"},"Facebook":{"label":"Facebook","name":"Facebook","selected":true,"value":false,"sortid":"11","shareid":"Facebook","sharetitle":"分享到FaceBook","event":"shareToFacebook","lang":"shareWeb_Facebook"},"Twitter":{"label":"Twitter","name":"Twitter","selected":true,"value":false,"sortid":"12","shareid":"Twitter","sharetitle":"分享到Twitter","event":"shareToTwitter","lang":"shareWeb_Twitter"},"LinkedIn":{"label":"LinkedIn","name":"LinkedIn","selected":true,"value":false,"sortid":"13","shareid":"LinkedIn","sharetitle":"分享到linkedIn","event":"shareToLinkedin","lang":"shareWeb_Linkedin"},"whatsapp":{"label":"whatsapp","name":"whatsapp","selected":true,"value":false,"sortid":"15","shareid":"whatsapp","sharetitle":"分享到whatsapp","event":"shareToWhatsapp","lang":"shareWeb_whatsapp"},"line":{"label":"line","name":"line","selected":true,"value":false,"sortid":"15","shareid":"line","sharetitle":"分享到line","event":"shareToLine","lang":"shareWeb_line"},"qq_weibo":{"label":"腾讯微博","name":"qq_weibo","selected":true,"value":true,"sortid":"3","shareid":"qq_weibo","sharetitle":"分享到腾讯微博","event":"shareToQQwb","lang":"shareWeb_QQWeiBo"}}